EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access

Analytical validation of a circulating tumor DNA assay using PhasED-Seq technology for detecting residual disease in B-cell malignancies

Nina Klimova, Sandra Close, David M Kurtz, Richard D Hockett, Laura Hyland

Oncotarget · 09.05.2025 · 16 (1) · 329-336

DOI: 10.18632/oncotarget.28719 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Oncotarget, online erschienen am 09.05.2025. Verfasst von Nina Klimova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Foresight Diagnostics, Boulder, CO 80301, USA. Hauptthemen laut MEDLINE: Neoplasm, Residual, Circulating Tumor DNA, Lymphoma, Large B-Cell, Diffuse, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasm, ResidualCirculating Tumor DNALymphoma, Large B-Cell, DiffuseHigh-Throughput Nucleotide SequencingBiomarkers, TumorHumansReproducibility of ResultsSensitivity and Specificity

Stichwörter der Autor:innen

CLARITYMRDPhasED-SeqctDNAresidual disease

Substanzen

Circulating Tumor DNABiomarkers, Tumor

Autor:innen und Institutionen

  • Foresight Diagnostics, Boulder, CO 80301, USA.

Zitieren

APA

Klimova, N., Close, S., Kurtz, D. M., Hockett, R. D., & Hyland, L. (2025). Analytical validation of a circulating tumor DNA assay using PhasED-Seq technology for detecting residual disease in B-cell malignancies. Oncotarget, 16(1), 329-336. https://doi.org/10.18632/oncotarget.28719

Vancouver

Klimova N, Close S, Kurtz DM, Hockett RD, Hyland L. Analytical validation of a circulating tumor DNA assay using PhasED-Seq technology for detecting residual disease in B-cell malignancies. Oncotarget. 2025;16(1):329-336. doi:10.18632/oncotarget.28719

BibTeX
@article{Klimova2025,
  author = {Klimova, Nina and Close, Sandra and Kurtz, David M and Hockett, Richard D and Hyland, Laura},
  title = {Analytical validation of a circulating tumor DNA assay using PhasED-Seq technology for detecting residual disease in B-cell malignancies},
  journal = {Oncotarget},
  year = {2025},
  volume = {16},
  number = {1},
  pages = {329--336},
  doi = {10.18632/oncotarget.28719}
}
Kostenlos starten →